Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
Doki N, Suyama M, Sasajima S, Ota J, Igarashi A, Mimura I, Morita H, Fujioka Y, Sugiyama D, Nishikawa H, Shimazu Y, Suda W, Takeshita K, Atarashi K, Hattori M, Sato E, Watakabe-Inamoto K, Yoshioka K, Najima Y, Kobayashi T, Kakihana K, Takahashi N, Sakamaki H, Honda K, Ohashi K. Doki N, et al. Among authors: shimazu y. Ann Hematol. 2017 Sep;96(9):1517-1523. doi: 10.1007/s00277-017-3069-8. Epub 2017 Jul 21. Ann Hematol. 2017. PMID: 28733895 Clinical Trial.
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis.
Murata M, Suzuki R, Nishida T, Shirane S, Shimazu Y, Minami Y, Mori T, Doki N, Kanda Y, Uchida N, Tanaka M, Ishikawa J, Togitani K, Fukuda T, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Kiyoi H. Murata M, et al. Among authors: shimazu y. Intern Med. 2020;59(16):1947-1956. doi: 10.2169/internalmedicine.4375-19. Epub 2020 Aug 15. Intern Med. 2020. PMID: 32801269 Free PMC article.
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
Shimazu Y, Mizuno S, Fuchida SI, Suzuki K, Tsukada N, Hanagaishi A, Itagaki M, Kataoka K, Kako S, Sakaida E, Yoshioka S, Iida S, Doki N, Oyake T, Ichinohe T, Kanda Y, Astuta Y, Takamatsu H; working group of the Japan Society for Transplantation, Cellular Therapy. Shimazu Y, et al. Cancer Sci. 2021 Dec;112(12):5034-5045. doi: 10.1111/cas.15163. Epub 2021 Oct 26. Cancer Sci. 2021. PMID: 34644446 Free PMC article.
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.
Shimazu Y, Murata M, Kondo T, Minami Y, Tachibana T, Doki N, Uchida N, Ozawa Y, Yano S, Fukuda T, Kato J, Ara T, Eto T, Ishikawa J, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, Nagamura-Inoue T; working group of the Japan Society for Transplantation and Cellular Therapy. Shimazu Y, et al. Hematol Oncol. 2022 Aug;40(3):442-456. doi: 10.1002/hon.3000. Epub 2022 Apr 12. Hematol Oncol. 2022. PMID: 35394658
Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosis.
Okada Y, Takenaka K, Murata M, Shimazu Y, Tachibana T, Ozawa Y, Uchida N, Wakayama T, Doki N, Sugio Y, Tanaka M, Masuko M, Kobayashi H, Ino K, Ishikawa J, Nakamae H, Matsuoka KI, Kanda Y, Fukuda T, Atsuta Y, Nagamura-Inoue T. Okada Y, et al. Among authors: shimazu y. Hematol Oncol. 2022 Dec;40(5):1076-1085. doi: 10.1002/hon.3058. Epub 2022 Aug 19. Hematol Oncol. 2022. PMID: 35964301
Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.
Suzuki K, Mizuno S, Shimazu Y, Fuchida SI, Hagiwara S, Itagaki M, Nishiwaki K, Hangaishi A, Karasuno T, Kikuchi T, Shimizu M, Nishikawa A, Kobayashi T, Sunami K, Hiramoto N, Uchiyama H, Maruyama Y, Kanda Y, Ichinohe T, Atsuta Y, Yano S, Kawamura K; Working Group of the Japan Society; for Transplantation and Cellular Therapy. Suzuki K, et al. Among authors: shimazu y. Eur J Haematol. 2023 Apr;110(4):444-454. doi: 10.1111/ejh.13922. Epub 2023 Jan 17. Eur J Haematol. 2023. PMID: 36597575
Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era.
Ishida H, Shimada H, Tanizawa A, Shimazu Y, Tachibana T, Doki N, Ara T, Matsuo Y, Nara M, Toubai T, Ino K, Nakamae H, Kato K, Kato K, Sato A, Hino M, Matsumoto K, Atsuta Y, Yasui M, Nagamura-Inoue T. Ishida H, et al. Among authors: shimazu y. Am J Hematol. 2023 Aug;98(8):E200-E203. doi: 10.1002/ajh.26959. Epub 2023 May 12. Am J Hematol. 2023. PMID: 37170859 Free article.
Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
Okada Y, Kimura F, Kurita N, Takahashi H, Shimazu Y, Mizuno S, Uchida N, Kataoka K, Hiramoto N, Ota S, Kako S, Tsukada N, Kanda Y, Kurahashi S, Doki N, Nishikawa A, Kim SW, Hangaishi A, Kanda J, Fukuda T, Atsuta Y, Kondo E, Kawamura K, Nakasone H. Okada Y, et al. Among authors: shimazu y. Cytotherapy. 2023 Nov;25(11):1212-1219. doi: 10.1016/j.jcyt.2023.05.015. Epub 2023 Jun 24. Cytotherapy. 2023. PMID: 37354150
245 results